Abstract:The aortouni-iliac device has the widest applicability of the currently available endovascular systems but open repair remains the only option for a large proportion of patients.
“…The proportion of AAA patients found suitable for EVAR has increased significantly, from a reported 20% in the early stage to 45% to 80% more recently. [5][6][7][8] This present study analyzes the correlation of aortic neck length to early and late clinical outcomes.…”
EVAR can be used for patients with a short aortic neck; however, it was associated with a significantly higher rate of early and late type I endoleaks, resulting in an increased use of proximal aortic cuffs for sealing the endoleaks.
“…The proportion of AAA patients found suitable for EVAR has increased significantly, from a reported 20% in the early stage to 45% to 80% more recently. [5][6][7][8] This present study analyzes the correlation of aortic neck length to early and late clinical outcomes.…”
EVAR can be used for patients with a short aortic neck; however, it was associated with a significantly higher rate of early and late type I endoleaks, resulting in an increased use of proximal aortic cuffs for sealing the endoleaks.
“…Especially calcified, tortuous, and narrowaccess vessels increase the risk for technical failures and need for secondary procedures. 8,9 Besides these, gender has also been shown to be a contributory risk factor for treating patients with challenging iliac vessels. 10 Therefore, an increasing number of low-profile devices have been introduced in clinical practice.…”
The INCRAFT AAA Stent Graft System provides a durable solution for patients with abdominal aortic aneurysms, with a low frequency of device-related events through 2 years of follow-up.
“…The dominant limiting factor in patient selection is the stent-graft itself [29,30]. Each device has specific and relatively restrictive requirements with regard to the diameter, length, and angulation of the proximal and distal attachment sites and to the ability of the iliofemoral arteries to accommodate the stent-graft delivery systems.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.